Celularity Inc. has announced a delay in filing its quarterly report on Form 10-Q for the period ending March 31, 2025. The company received a notice from Nasdaq's Listings Qualification Staff on May 28, 2025, indicating non-compliance with Nasdaq's continued listing requirements due to this delay. Celularity submitted a compliance plan on August 1, 2025, and was granted until August 31, 2025, to file the required Form 10-Q for both the periods ending March 31, 2025, and June 30, 2025, to avoid potential delisting.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.